Supernus Pharmaceuticals (SUPN) Gross Margin (2013 - 2026)
Supernus Pharmaceuticals (SUPN) reported Gross Margin of 84.63% for Q2 2026, down 5.20 percentage points from 89.83% a year earlier.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) Gross Margin (2013 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Supernus Pharmaceuticals' Gross Margin came in at 88.27%, down 0.26 percentage points year-over-year; for FY2025, it came in at 89.63%, up 1.40 percentage points from FY2024.
- Gross Margin has a five-year change of -0.29 percentage points (FY2020 to FY2025).
- By year, Gross Margin came in at 88.23% in FY2024 (+2.02 pp), 86.21% in FY2023 (-0.72 pp), 86.93% in FY2022 (-0.13 pp) and 87.05% in FY2021 (-2.87 pp).
- The Q2 2026 figure ranks as the lowest quarterly Gross Margin since Q2 2023.
- Year over year, Gross Margin gained in five of the last seven quarters, with an average year-over-year change of +0.01 percentage points.
- The high point for year-over-year Gross Margin in five years was Q2 2022 (a gain of 5.68 percentage points); the low point was Q2 2026 (a drop of 5.20 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Supernus Pharmaceuticals | 2.59 Bn | 1.25 Bn | 185.39 Mn | 84.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 84.63% |
| Dec 31, 2025 | 89.13% |
| Sep 30, 2025 | 90.13% |
| Jun 30, 2025 | 89.83% |
| Mar 31, 2025 | 89.48% |
| Dec 31, 2024 | 85.01% |
| Sep 30, 2024 | 89.99% |
| Jun 30, 2024 | 89.36% |
| Mar 31, 2024 | 88.65% |
| Dec 31, 2023 | 88.06% |
| Sep 30, 2023 | 87.26% |
| Jun 30, 2023 | 84.44% |
| Mar 31, 2023 | 84.74% |
| Dec 31, 2022 | 86.28% |
| Sep 30, 2022 | 85.41% |
| Jun 30, 2022 | 87.97% |
| Mar 31, 2022 | 88.24% |
| Dec 31, 2021 | 89.32% |
| Sep 30, 2021 | 87.82% |
| Jun 30, 2021 | 82.29% |
API Access
Supernus Pharmaceuticals Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();